Advanced search
Publication Cover
Prehospital Emergency Care Latest Articles
Submit an article Journal homepage
34
Views
0
CrossRef citations to date
0
Altmetric
Case Conference

Acute Non-ST Segment Elevation Myocardial Infarction Following Intravenous Injection of Sublingual Suboxone

Lucas Belmorea Touro University Osteopathic Medical School, Las Vegas, Nevada
,
Timothy Ahna Touro University Osteopathic Medical School, Las Vegas, Nevada
,
Eric Nguyena Touro University Osteopathic Medical School, Las Vegas, Nevada
&
Timothy Lenzb Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, WisconsinCorrespondence[email protected]
Received 22 Jan 2024, Accepted 14 Jun 2024, Published online: 23 Jul 2024

References

  • Ducharme S, Fraser R, Gill K. Update on the clinical use of buprenorphine: in opioid-related disorders. Can Fam Physician. 2012;58(1):37–41.
  • Basit H, Malik A, Huecker MR. Non–ST-segment elevation myocardial infarction. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30020600.
  • Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015;16 Suppl 1(Suppl 1):S27–S31. doi:10.1111/pme.12915.
  • Blazes CK, Morrow JD. Reconsidering the usefulness of adding naloxone to buprenorphine. Front Psychiatry. 2020;11:549272. doi:10.3389/fpsyt.2020.549272.
  • Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend. 2003;70(2 Suppl):S29–S37. doi:10.1016/s0376-8716(03)00057-7.
  • Butler SF, Black RA, Severtson SG, Dart RC, Green JL. Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers. J Subst Abuse Treat. 2018;84:42–9. doi:10.1016/j.jsat.2017.10.010.
  • Nabati M, Dehghan Z, Kalantari B, Yazdani J. Corrected QT interval prolongations in patients with non-ST-elevation acute coronary syndrome. J Tehran Heart Cent. 2018;13(4):173–9.
  • Sansone RA, Sansone LA. Buprenorphine treatment for narcotic addiction: not without risks. Innov Clin Neurosci. 2015;12(3-4):32–6.
  • Bramnert M. The effect of naloxone on blood pressure, heart rate, plasma catecholamines, renin activity and aldosterone following exercise in healthy males. Regul Pept. 1988;22(4):295–301. doi:10.1016/0167-0115(88)90106-1.
  • Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature. 1979;280(5719):235–6. doi:10.1038/280235a0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Aurora. Learn more.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.